It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CERS’s FA Score shows that 0 FA rating(s) are green whileINGN’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CERS’s TA Score shows that 2 TA indicator(s) are bullish while INGN’s TA Score has 5 bullish TA indicator(s).
CERS (@Medical/Nursing Services) experienced а -3.85% price change this week, while INGN (@Medical/Nursing Services) price change was +7.49% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.89%. For the same industry, the average monthly price growth was +1.03%, and the average quarterly price growth was +3.47%.
CERS is expected to report earnings on Oct 30, 2025.
INGN is expected to report earnings on Nov 05, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
CERS | INGN | CERS / INGN | |
Capitalization | 240M | 190M | 126% |
EBITDA | -8.5M | -12.97M | 66% |
Gain YTD | -18.831 | -23.337 | 81% |
P/E Ratio | N/A | N/A | - |
Revenue | 185M | 340M | 54% |
Total Cash | 80.9M | 119M | 68% |
Total Debt | 99.4M | 19.2M | 518% |
CERS | INGN | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 59 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 35 Fair valued | 82 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 94 | |
PRICE GROWTH RATING 1..100 | 85 | 63 | |
P/E GROWTH RATING 1..100 | 100 | 59 | |
SEASONALITY SCORE 1..100 | 85 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CERS's Valuation (35) in the Medical Specialties industry is somewhat better than the same rating for INGN (82). This means that CERS’s stock grew somewhat faster than INGN’s over the last 12 months.
CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as INGN (100). This means that CERS’s stock grew similarly to INGN’s over the last 12 months.
INGN's SMR Rating (94) in the Medical Specialties industry is in the same range as CERS (97). This means that INGN’s stock grew similarly to CERS’s over the last 12 months.
INGN's Price Growth Rating (63) in the Medical Specialties industry is in the same range as CERS (85). This means that INGN’s stock grew similarly to CERS’s over the last 12 months.
INGN's P/E Growth Rating (59) in the Medical Specialties industry is somewhat better than the same rating for CERS (100). This means that INGN’s stock grew somewhat faster than CERS’s over the last 12 months.
CERS | INGN | |
---|---|---|
RSI ODDS (%) | N/A | 7 days ago81% |
Stochastic ODDS (%) | 2 days ago78% | 2 days ago75% |
Momentum ODDS (%) | 2 days ago84% | 2 days ago79% |
MACD ODDS (%) | 2 days ago84% | 2 days ago83% |
TrendWeek ODDS (%) | 2 days ago85% | 2 days ago76% |
TrendMonth ODDS (%) | 2 days ago82% | 2 days ago82% |
Advances ODDS (%) | 21 days ago76% | 2 days ago72% |
Declines ODDS (%) | 5 days ago84% | 6 days ago81% |
BollingerBands ODDS (%) | N/A | 2 days ago78% |
Aroon ODDS (%) | 2 days ago86% | 2 days ago82% |
A.I.dvisor indicates that over the last year, CERS has been loosely correlated with LAB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then LAB could also see price increases.
Ticker / NAME | Correlation To CERS | 1D Price Change % | ||
---|---|---|---|---|
CERS | 100% | +3.31% | ||
LAB - CERS | 50% Loosely correlated | -1.92% | ||
SGHT - CERS | 48% Loosely correlated | -2.83% | ||
PACB - CERS | 47% Loosely correlated | -7.04% | ||
NNOX - CERS | 47% Loosely correlated | +1.29% | ||
ITGR - CERS | 46% Loosely correlated | -0.99% | ||
More |
A.I.dvisor indicates that over the last year, INGN has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then VCYT could also see price increases.
Ticker / NAME | Correlation To INGN | 1D Price Change % | ||
---|---|---|---|---|
INGN | 100% | +8.49% | ||
VCYT - INGN | 46% Loosely correlated | +2.27% | ||
STRRP - INGN | 44% Loosely correlated | +9.05% | ||
OSUR - INGN | 39% Loosely correlated | +0.36% | ||
ITGR - INGN | 34% Loosely correlated | -0.99% | ||
CERS - INGN | 32% Poorly correlated | +3.31% | ||
More |